Publications by authors named "F Calonaci"

Following myomectomy the rate of fertility is restored and pregnancy may be attempted with a good outcome. In the present study a 3 month treatment with OCs in a group of women after a myomectomy was evaluated. The drug compliance and side effects, the benefits of OC in order to reduce symptoms, to increase post-surgical hemoglobin levels and to avoid an early pregnancy after myomectomy were analyzed.

View Article and Find Full Text PDF

Objective: To compare the effectiveness and safety of harmonic scalpel versus electrosurgery to reduce blood loss during laparoscopic myomectomy.

Design: Prospective randomized controlled study.

Setting: Tertiary referral centers for gynecological care.

View Article and Find Full Text PDF

Background: Follistatin is an activin-binding protein produced by several tissues, including endometrium and endometriotic implants. We aimed to quantify follistatin in patients with ovarian endometriosis and investigate its value as a diagnostic marker.

Methods: Women undergoing laparoscopic excision of ovarian endometrioma (n = 52) or other benign ovarian cysts (n = 52) were studied, plus women with non-ovarian endometriosis (n = 11) and healthy controls (n = 27).

View Article and Find Full Text PDF

By using the activity-based cost/management (ABC/M) system we computed and compared costs needed for laparoscopic tubal sterilization (LTS) and Essure hysteroscopic tubal occlusion (EHTO). We found that total health costs related to consultation and presurgery did not differ between LTS and EHTO; EHTO has low recovery unit costs but is more costly for the operating theater, mainly due to Essure microinserts.

View Article and Find Full Text PDF
Article Synopsis
  • Urocortin, a neuropeptide from the human endometrium, was studied to determine its effectiveness as a diagnostic marker for ovarian endometrioma compared to benign ovarian cysts.
  • Plasma urocortin levels were significantly higher in women with endometriomas than in those with nonendometriotic cysts, showing an 88% detection rate for endometriomas vs. 65% for the standard marker CA 125.
  • The study suggests that measuring plasma urocortin may improve differential diagnosis for endometriomas, providing a promising alternative to existing markers.
View Article and Find Full Text PDF